Last 12 months
Inside the activity.
0 purchase rows · 21 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 05, 2024 Filed Sep 9, 2024 20:45 UTC |
MILLER DAVID BDirector
|
GrantDividend Equivalent Units · Derivative | 0.391 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023679 · form4.xml · derivative · entry 3 MILLER DAVID B · CIK 0001167138 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.285 Underlying: Common Stock · 0.391 shares Expires not disclosed F7 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Incentive Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F8 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F7 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Incentive Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F8 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F9 · balance_after: The balance adjusted down 0.059 DEUs to correct an administrative error on a previously reported form 4. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:45 UTC |
MILLER DAVID BDirector
|
GrantDividend Equivalent Units · Derivative | 0.699 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023679 · form4.xml · derivative · entry 2 MILLER DAVID B · CIK 0001167138 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10.232 Underlying: Common Stock · 0.699 shares Expires not disclosed F5 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F6 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F6 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:45 UTC |
MILLER DAVID BDirector
|
GrantDividend Equivalent Units · Derivative | 0.382 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023679 · form4.xml · derivative · entry 1 MILLER DAVID B · CIK 0001167138 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.711 Underlying: Common Stock · 0.382 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · shares: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F1 · balance_after: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. F4 · balance_after: Balance adjusted up 0.706 DEUs to correct an administrative error on a previously reported form 4. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:45 UTC |
Jeff Charles GalagherEVP, Chief Financial Officer
|
GrantDividend Equivalent Units · Derivative | 0.484 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023680 · form4.xml · derivative · entry 1 Jeff Charles Galagher · CIK 0002014914 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.029 Underlying: Common Stock · 0.484 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Incentive Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on March 7, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Incentive Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on March 7, 2024. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 16:49 UTC |
Segal BlakeSVP, QuickChek
|
GrantDividend Equivalent Units · Derivative | 0.396 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023687 · form4.xml · derivative · entry 4 Segal Blake · CIK 0001882861 · SVP, QuickChek 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.301 Underlying: Common Stock · 0.396 shares Expires not disclosed F6 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F7 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F6 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F7 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 16:49 UTC |
Segal BlakeSVP, QuickChek
|
GrantDividend Equivalent Units · Derivative | 0.487 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023687 · form4.xml · derivative · entry 3 Segal Blake · CIK 0001882861 · SVP, QuickChek 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.378 Underlying: Common Stock · 0.487 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F5 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 16:49 UTC |
Segal BlakeSVP, QuickChek
|
GrantDividend Equivalent Units · Derivative | 0.623 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023687 · form4.xml · derivative · entry 2 Segal Blake · CIK 0001882861 · SVP, QuickChek 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.114 Underlying: Common Stock · 0.623 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 16:49 UTC |
Segal BlakeSVP, QuickChek
|
GrantDividend Equivalent Units · Derivative | 0.223 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023687 · form4.xml · derivative · entry 1 Segal Blake · CIK 0001882861 · SVP, QuickChek 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.669 Underlying: Common Stock · 0.223 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on September 13, 2021. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on September 13, 2021. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:49 UTC |
Turner RosemaryDirector
|
GrantDividend Equivalent Units · Derivative | 0.391 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023688 · form4.xml · derivative · entry 3 Turner Rosemary · CIK 0001863747 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.285 Underlying: Common Stock · 0.391 shares Expires not disclosed F6 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F7 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units, in accordance with their deferral election form, to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units, in accordance with their deferral election form, to the reporting person's termination of service form the Board. F6 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F7 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:49 UTC |
Turner RosemaryDirector
|
GrantDividend Equivalent Units · Derivative | 0.537 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023688 · form4.xml · derivative · entry 2 Turner Rosemary · CIK 0001863747 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.831 Underlying: Common Stock · 0.537 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2023. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units, in accordance with their deferral election form, to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units, in accordance with their deferral election form, to the reporting person's termination of service form the Board. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2023. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:49 UTC |
Turner RosemaryDirector
|
GrantDividend Equivalent Units · Derivative | 0.699 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023688 · form4.xml · derivative · entry 1 Turner Rosemary · CIK 0001863747 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10.232 Underlying: Common Stock · 0.699 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 16:39 UTC |
CHUMLEY ROBERT JSVP, Chief Digital Officer
|
GrantDividend Equivalent Units · Derivative | 0.396 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023667 · form4.xml · derivative · entry 3 CHUMLEY ROBERT J · CIK 0001684248 · SVP, Chief Digital Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.301 Underlying: Common Stock · 0.396 shares Expires not disclosed F5 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Incentive Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F6 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Incentive Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F6 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 16:39 UTC |
CHUMLEY ROBERT JSVP, Chief Digital Officer
|
GrantDividend Equivalent Units · Derivative | 0.487 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023667 · form4.xml · derivative · entry 2 CHUMLEY ROBERT J · CIK 0001684248 · SVP, Chief Digital Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.378 Underlying: Common Stock · 0.487 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSU. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSU. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 16:39 UTC |
CHUMLEY ROBERT JSVP, Chief Digital Officer
|
GrantDividend Equivalent Units · Derivative | 0.667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023667 · form4.xml · derivative · entry 1 CHUMLEY ROBERT J · CIK 0001684248 · SVP, Chief Digital Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.763 Underlying: Common Stock · 0.667 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSU. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSU. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:40 UTC |
Keyes James WDirector
|
GrantDividend Equivalent Units · Derivative | 0.391 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023669 · form4.xml · derivative · entry 2 KEYES JAMES W · CIK 0001235367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.285 Underlying: Common Stock · 0.391 shares Expires not disclosed F4 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Incentive Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Incentive Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F5 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:40 UTC |
Keyes James WDirector
|
GrantDividend Equivalent Units · Derivative | 0.699 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023669 · form4.xml · derivative · entry 1 KEYES JAMES W · CIK 0001235367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10.232 Underlying: Common Stock · 0.699 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:38 UTC |
MURPHY ROBERT MADISONDirector
|
GrantDividend Equivalent Units · Derivative | 0.391 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023665 · form4.xml · derivative · entry 2 MURPHY ROBERT MADISON · CIK 0001216894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.285 Underlying: Common Stock · 0.391 shares Expires not disclosed F4 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F5 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:38 UTC |
MURPHY ROBERT MADISONDirector
|
GrantDividend Equivalent Units · Derivative | 0.699 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023665 · form4.xml · derivative · entry 1 MURPHY ROBERT MADISON · CIK 0001216894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10.232 Underlying: Common Stock · 0.699 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:55 UTC |
West Malynda KEVP & Chief Operating Officer
|
GrantDividend Equivalent Units · Derivative | 1.233 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023695 · form4.xml · derivative · entry 3 West Malynda K · CIK 0001381734 · EVP & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.05 Underlying: Common Stock · 1.233 shares Expires not disclosed F5 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F6 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F6 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:55 UTC |
West Malynda KEVP & Chief Operating Officer
|
GrantDividend Equivalent Units · Derivative | 1.106 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023695 · form4.xml · derivative · entry 2 West Malynda K · CIK 0001381734 · EVP & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.95 Underlying: Common Stock · 1.106 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:55 UTC |
West Malynda KEVP & Chief Operating Officer
|
GrantDividend Equivalent Units · Derivative | 1.379 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023695 · form4.xml · derivative · entry 1 West Malynda K · CIK 0001381734 · EVP & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20.176 Underlying: Common Stock · 1.379 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:47 UTC |
Phillips Jeanne LinderDirector
|
GrantDividend Equivalent Units · Derivative | 0.391 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023684 · form4.xml · derivative · entry 4 Phillips Jeanne Linder · CIK 0001759743 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.285 Underlying: Common Stock · 0.391 shares Expires not disclosed F9 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Incentive Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F10 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F9 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Incentive Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F10 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:47 UTC |
Phillips Jeanne LinderDirector
|
GrantDividend Equivalent Units · Derivative | 0.283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023684 · form4.xml · derivative · entry 3 Phillips Jeanne Linder · CIK 0001759743 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.553 Underlying: Common Stock · 0.283 shares Expires not disclosed F7 · security: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person on in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F7 · shares: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person on in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F7 · balance_after: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person on in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. F8 · balance_after: Balance adjusted up .865 to correct an administrative error on a previously reported form 4. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:47 UTC |
Phillips Jeanne LinderDirector
|
GrantDividend Equivalent Units · Derivative | 0.537 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023684 · form4.xml · derivative · entry 2 Phillips Jeanne Linder · CIK 0001759743 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.831 Underlying: Common Stock · 0.537 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2023. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2023. F6 · balance_after: Balance adjusted down .865 to correct an administrative error on a previously reported form 4. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:47 UTC |
Phillips Jeanne LinderDirector
|
GrantDividend Equivalent Units · Derivative | 0.699 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023684 · form4.xml · derivative · entry 1 Phillips Jeanne Linder · CIK 0001759743 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10.232 Underlying: Common Stock · 0.699 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:43 UTC |
Taylor Jack TDirector
|
GrantDividend Equivalent Units · Derivative | 0.391 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023675 · form4.xml · derivative · entry 3 Taylor Jack T · CIK 0001570352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.285 Underlying: Common Stock · 0.391 shares Expires not disclosed F7 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Incentive Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F8 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F7 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Incentive Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F8 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F9 · balance_after: Balance adjusted down 0.472 DEUs to correct an administrative error on a previously reported form 4. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:43 UTC |
Taylor Jack TDirector
|
GrantDividend Equivalent Units · Derivative | 0.477 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023675 · form4.xml · derivative · entry 2 Taylor Jack T · CIK 0001570352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.129 Underlying: Common Stock · 0.477 shares Expires not disclosed F4 · security: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F4 · balance_after: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. F6 · balance_after: Balance adjusted up 1.151 DEUs to correct an administrative error on a previously reported form 4. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:43 UTC |
Taylor Jack TDirector
|
GrantDividend Equivalent Units · Derivative | 0.699 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023675 · form4.xml · derivative · entry 1 Taylor Jack T · CIK 0001570352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10.232 Underlying: Common Stock · 0.699 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:47 UTC |
Smith Donald R JrVP, CAO & Treasurer
|
GrantDividend Equivalent Units · Derivative | 0.22 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023682 · form4.xml · derivative · entry 3 Smith Donald R Jr · CIK 0001583749 · VP, CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.723 Underlying: Common Stock · 0.22 shares Expires not disclosed F5 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F6 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F6 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:47 UTC |
Smith Donald R JrVP, CAO & Treasurer
|
GrantDividend Equivalent Units · Derivative | 0.266 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023682 · form4.xml · derivative · entry 2 Smith Donald R Jr · CIK 0001583749 · VP, CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.389 Underlying: Common Stock · 0.266 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:47 UTC |
Smith Donald R JrVP, CAO & Treasurer
|
GrantDividend Equivalent Units · Derivative | 0.311 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023682 · form4.xml · derivative · entry 1 Smith Donald R Jr · CIK 0001583749 · VP, CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.556 Underlying: Common Stock · 0.311 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:43 UTC |
Clyde R AndrewDirector · President & CEO
|
GrantDividend Equivalent Units · Derivative | 4.183 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023676 · form4.xml · derivative · entry 3 Clyde R Andrew · CIK 0001582735 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13.74 Underlying: Common Stock · 4.183 shares Expires not disclosed F5 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Incentive Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F6 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Incentive Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F6 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:43 UTC |
Clyde R AndrewDirector · President & CEO
|
GrantDividend Equivalent Units · Derivative | 5.089 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023676 · form4.xml · derivative · entry 2 Clyde R Andrew · CIK 0001582735 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45.775 Underlying: Common Stock · 5.089 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:43 UTC |
Clyde R AndrewDirector · President & CEO
|
GrantDividend Equivalent Units · Derivative | 6.494 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023676 · form4.xml · derivative · entry 1 Clyde R Andrew · CIK 0001582735 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95.024 Underlying: Common Stock · 6.494 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:37 UTC |
Bacon Renee MSVP, Sales & Ops & CMO
|
GrantDividend Equivalent Units · Derivative | 0.396 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023663 · form4.xml · derivative · entry 3 Bacon Renee M · CIK 0001768052 · SVP, Sales & Ops & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.301 Underlying: Common Stock · 0.396 shares Expires not disclosed F5 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Incentive Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F6 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Incentive Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F6 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:37 UTC |
Bacon Renee MSVP, Sales & Ops & CMO
|
GrantDividend Equivalent Units · Derivative | 0.531 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023663 · form4.xml · derivative · entry 2 Bacon Renee M · CIK 0001768052 · SVP, Sales & Ops & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.776 Underlying: Common Stock · 0.531 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:37 UTC |
Bacon Renee MSVP, Sales & Ops & CMO
|
GrantDividend Equivalent Units · Derivative | 0.623 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023663 · form4.xml · derivative · entry 1 Bacon Renee M · CIK 0001768052 · SVP, Sales & Ops & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.114 Underlying: Common Stock · 0.623 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:36 UTC |
Landen Diane NDirector
|
GrantDividend Equivalent Units · Derivative | 0.391 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023661 · form4.xml · derivative · entry 2 Landen Diane N · CIK 0001583746 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.285 Underlying: Common Stock · 0.391 shares Expires not disclosed F4 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F5 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:36 UTC |
Landen Diane NDirector
|
GrantDividend Equivalent Units · Derivative | 0.699 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023661 · form4.xml · derivative · entry 1 Landen Diane N · CIK 0001583746 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10.232 Underlying: Common Stock · 0.699 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. Read SEC document |
| August 27, 2024 Filed Aug 28, 2024 21:58 UTC |
Keyes James WDirector
|
SaleCommon Stock | 2,000 | $511.54 | $1,023,080.00 |
DisclosureSEC source: 0001127602-24-023085 · form4.xml · nonDerivative · entry 1 KEYES JAMES W · CIK 0001235367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,114 Read SEC document |
| August 08, 2024 Filed Aug 9, 2024 22:42 UTC |
MURPHY ROBERT MADISONDirector
|
SaleCommon Stock | 13,454 | $514.38 | $6,920,468.52 |
DisclosureSEC source: 0001127602-24-021962 · form4.xml · nonDerivative · entry 1 MURPHY ROBERT MADISON · CIK 0001216894 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 382,930 Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 20:39 UTC |
MURPHY ROBERT MADISONDirector
|
SaleCommon Stock | 16,755 | $514.54 | $8,621,117.70 |
DisclosureSEC source: 0001127602-24-021902 · form4.xml · nonDerivative · entry 1 MURPHY ROBERT MADISON · CIK 0001216894 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 396,384 Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 21:06 UTC |
DEMING CLAIBORNE PDirector
|
GrantCommon Stock | 63.903 | $469.46 | $29,999.90 |
DisclosureSEC source: 0001127602-24-019615 · form4.xml · nonDerivative · entry 1 DEMING CLAIBORNE P · CIK 0001166951 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,790.254 F1 · shares: The shares represent fully-vested restricted stock units ("RSUs") issued in lieu of the reporting person's quarterly cash retainer(s). The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units to the reporting person's termination of service from the Board, in accordance with their deferral election form. F2 · shares: Award granted under the 2023 Omnibus Incentive Plan. Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 21:03 UTC |
MILLER DAVID BDirector
|
GrantCommon Stock | 53.253 | $469.46 | $25,000.15 |
DisclosureSEC source: 0001127602-24-019609 · form4.xml · nonDerivative · entry 1 MILLER DAVID B · CIK 0001167138 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,270.398 F1 · shares: The shares represent fully-vested restricted stock units ("RSUs") issued in lieu of the reporting person's quarterly cash retainer(s). The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units to the reporting person's termination of service from the Board, in accordance with their deferral election form. F2 · shares: Award granted under the 2023 Omnibus Incentive Plan. Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 20:56 UTC |
Taylor Jack TDirector
|
GrantCommon Stock | 66.566 | $469.46 | $31,250.07 |
DisclosureSEC source: 0001127602-24-019595 · form4.xml · nonDerivative · entry 1 Taylor Jack T · CIK 0001570352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,361.924 F1 · shares: The shares represent fully-vested restricted stock units ("RSUs") issued in lieu of the reporting person's quarterly cash retainer(s). The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units to the reporting person's termination of service from the Board, in accordance with their deferral election form. F2 · shares: Award granted under the 2023 Omnibus Incentive Plan. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:04 UTC |
Click Christopher AEVP, Strategy, Growth & Innova
|
GrantDividend Equivalent Units · Derivative | 0.546 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017906 · form4.xml · derivative · entry 3 Click Christopher A · CIK 0001831593 · EVP, Strategy, Growth & Innova 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.107 Underlying: Common Stock · 0.546 shares Expires not disclosed F5 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F6 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F6 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:04 UTC |
Click Christopher AEVP, Strategy, Growth & Innova
|
GrantDividend Equivalent Units · Derivative | 0.548 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017906 · form4.xml · derivative · entry 2 Click Christopher A · CIK 0001831593 · EVP, Strategy, Growth & Innova 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.891 Underlying: Common Stock · 0.548 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:04 UTC |
Click Christopher AEVP, Strategy, Growth & Innova
|
GrantDividend Equivalent Units · Derivative | 0.702 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017906 · form4.xml · derivative · entry 1 Click Christopher A · CIK 0001831593 · EVP, Strategy, Growth & Innova 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.491 Underlying: Common Stock · 0.702 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 22:32 UTC |
GOEBEL DAVIDDirector
|
GrantDividend Equivalent Units · Derivative | 0.441 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017974 · form4.xml · derivative · entry 3 GOEBEL DAVID · CIK 0001137523 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.894 Underlying: Common Stock · 0.441 shares Expires not disclosed F6 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F7 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F6 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F7 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 22:32 UTC |
GOEBEL DAVIDDirector
|
GrantDividend Equivalent Units · Derivative | 0.605 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017974 · form4.xml · derivative · entry 2 GOEBEL DAVID · CIK 0001137523 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.294 Underlying: Common Stock · 0.605 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2023. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.